We recommend you include the following information in your citation. Look below the item for additional data you may want to include.
Contact Owning Institution
All fields are required.
Request Text
Requests for a digital copy can be submitted through the Library, Special Collections (UC San Francisco) request system, Aeon.
Click the button below to submit your request. Please note that you will need to create an Aeon account or log in to your existing account.
Download Item
Please use this item responsibly. Check the rights information for this item to see if it has copyright restrictions. Note that even if the item is protected by copyright, you may be able to use it for educational, research, or other purposes. To learn more, read Calisphere's terms of use.
Do you need a bigger file? To obtain an alternate file type or higher resolution copy, please
contact the owning institution.
Evaluation of viral resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1-Infected Patients Before and After 6 Months of Single or Double Antiretroviral Therapy
Creator
Brites, Carlos Bahia, Fabianna Gilbert, Mark Pedroso, Célia Badaro, Roberto
Date Created and/or Issued
2001-08
Publication Information
Digital resource published by the Regents of the University of California
Copyrighted Transmission or reproduction of materials protected by copyright beyond that allowed by fair use requires the written permission of the copyright owners. Works not in the public domain cannot be commercially exploited without permission of the copyright owner. Responsibility for any use rests exclusively with the owner.
Description
Citation/Reference: Article published in the Brazilian Journal of Infectious Diseases, Vol. 5, No. 4, August 2001
If you're wondering about permissions and what you can do with this item, a good starting point is the "rights information" on this page. See our terms of use for more tips.
Share your story
Has Calisphere helped you advance your research, complete a project, or find something meaningful? We'd love to hear about it; please send us a message.
